Qilu Hospital of Shandong University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1890-01-01

Employees: -

Market Cap: -

Website: https://www.qiluhospital.com

Clinical Trials

Risk Factors for Complications After Cranioplasty

Recruiting

Conditions: Cranioplasty
Postoperative Complications
Risk Assessment

First Posted Date: 2024-12-18

Last Posted Date: 2024-12-20

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 1000

Registration Number: NCT06740773

Locations: 🇨🇳
Department of Neurosurgery, Daping Hospital of Army Medical University, Chongqing, Chongqing, China
🇨🇳
Department of Neurosurgery, Tang-Du Hospital, Xi'an, Shaanxi, China
🇨🇳
Department of Neurosurgery, Qilu Hospital of Shandong University, Jinan, Shandong, China

Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer

Phase 2

Recruiting

Conditions: Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer

Interventions: Drug: Fluzoparib
Drug: Paclitaxel
Drug: Bevacizumab
Drug: Carboplatin

First Posted Date: 2024-12-16

Last Posted Date: 2024-12-16

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 105

Registration Number: NCT06735326

Locations: 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China

First-line Treatment with RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)

Phase 2

Not yet recruiting

Conditions: HER2-positive Gastric Cancer
Metastatic Gastric Cancer
Unresectable Gastric Carcinoma

Interventions: Drug: Disitamab Vedotin
Drug: Sintilimab
Drug: Trastuzumab
Drug: Oxaliplatin
Drug: S-1
Drug: Capecitabine
Drug: 5-FU
Drug: Cisplatin

First Posted Date: 2024-12-12

Last Posted Date: 2024-12-12

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 110

Registration Number: NCT06730373

Locations: 🇨🇳
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
🇨🇳
Binzhou Medical University Hospital, Binzhou, Shandong, China
🇨🇳
Shengli Oilfield Central Hospital, Dongying, Shandong, China

and more 16 locations

First-Line and Neoadjuvant Immunotherapy for Gastric Cancer

Recruiting

Conditions: Advanced Gastric Cancer
Locally Advanced Gastric Carcinoma

Interventions: Drug: ICI plus Chemothearpy
Drug: Chemotherapy

First Posted Date: 2024-12-11

Last Posted Date: 2024-12-11

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 500

Registration Number: NCT06727981

Locations: 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China

Compound Danshen Dripping Pill for Diabetic Microvascular Angina

Phase 4

Not yet recruiting

Conditions: Diabetic Microvascular Angina

Interventions: Drug: Danshen Dripping Pill
Drug: Placebo

First Posted Date: 2024-12-11

Last Posted Date: 2024-12-11

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 162

Registration Number: NCT06727890

Locations: 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
🇨🇳
Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
🇨🇳
The First Affiliated Hospital of Shandong First Medical University/Shandong Province Qianfoshan Hospital, Jinan, Shandong, China

An Artificial Intelligence System for ROSE of EUS-FNA Sample: a Prospective, Multicenter, Diagnostic Study.

Recruiting

Conditions: The Malignant Lesions and Non-malignant Lesions of Pancreas, Bile Duct, Liver and Lymph Node

First Posted Date: 2024-12-05

Last Posted Date: 2024-12-05

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 236

Registration Number: NCT06718725

Locations: 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China

Comparision of Endoscopic Discectomy and Microdiscectomy for the Treatment of Lumbar Spinal Stenosis

Not Applicable

Not yet recruiting

Conditions: Lumbar Spinal Stenosis

First Posted Date: 2024-12-05

Last Posted Date: 2024-12-05

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 324

Registration Number: NCT06719037

Vericiguat for Heart Failure With Reduced Ejection Fraction After Myocardial Infarction

Not yet recruiting

Conditions: HFrEF - Heart Failure With Reduced Ejection Fraction
Myocardial Infarction (MI)

Interventions: Drug: Vericiguat Oral Tablet [Verquvo]
Drug: Prescription Drugs

First Posted Date: 2024-12-04

Last Posted Date: 2024-12-04

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 210

Registration Number: NCT06717204

Locations: 🇨🇳
Qilu Hospital of Shandong University, Jinan, Shandong, China
🇨🇳
Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
🇨🇳
The First Affiliated Hospital of Shandong First Medical University/Shandong Province Qianfoshan Hospital, Jinan, Shandong, China

Multimodal Neurological Monitoring Strategy After Receiving ECPR

Not Applicable

Not yet recruiting

Conditions: Cardiac Arrest

First Posted Date: 2024-12-02

Last Posted Date: 2024-12-02

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 654

Registration Number: NCT06711016

Locations: 🇨🇳
Qilu Hospital, Jinan, Shandong, China

Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients

Not Applicable

Not yet recruiting

Conditions: Stroke

First Posted Date: 2024-11-25

Last Posted Date: 2024-11-25

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 120

Registration Number: NCT06704074

Locations: 🇨🇳
a Head-mounted-display VR device, Jinan, Shangdong, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy